Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 3/2005

01-06-2005

Hepatofugal portal flow due to acute cellular rejection

Authors: Y. Kyoden, Y. Sugawara, Y. Matsui, Y. Kishi, N. Akamatsu, M. Makuuchi

Published in: Abdominal Radiology | Issue 3/2005

Login to get access

Abstract

We describe a case of living donor liver transplantation with hepatofugal portal flow caused by acute cellular rejection. The reversed portal flow was corrected by splenectomy and ligation of the residual collateral veins. Hepatofugal flow causes ischemic damage to the graft, which does not normalize spontaneously. In this particular case, meticulous Doppler ultrasound examination and prompt response to reversed portal flow salvaged the graft.
Literature
1.
Takayama, T, Makuuchi, M, Kubota, K,  et al. 2000Living-related transplantation of left liver plus caudate lobeJ Am Coll Surg190635638CrossRefPubMed
2.
Urata, K, Kawasaki, S, Matsunami, H,  et al. 1995Calculation of child and adult standard liver volume for liver transplantationHepatology2113171321CrossRefPubMed
3.
Sugawara, Y, Makuuchi, M, Kaneko, J,  et al. 2002Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantationClin Transpl16102106CrossRef
4.
Handengue, A, Lebrec, D, Moreau, R,  et al. 1993Persistence of systemic and splanchnic hyperkinetic circulation in liver transplantation patientsHepatology17175178CrossRefPubMed
5.
DeCarlis, L, Favero, E, Rondinara, G,  et al. 1992The role of spontaneous portosystemic shunts in the course of orthotopic liver transplantationTranspl Int5914CrossRefPubMed
6.
Sugimoto, H, Kaneko, T, Marui, Y,  et al. 2001Reversal of portal flow after acute rejection in living-donor liver transplantationJ Hepatobiliary Pancreat Surg8573576CrossRefPubMed
7.
Cescon, M, Sugawara, Y, Takayama, T,  et al. 2001Role of splenectomy in living donor transplantation for adultsHepatogastroenterology49721723
8.
Cescon, M, Sugawara, Y, Kaneko, J,  et al. 2001Restoration of portal vein flow by splenorenal shunt ligation and splenectomy after living-related liver transplantationHepatogastroenterology4814531454PubMed
9.
Reding, R, Gras, J, Sokal, E,  et al. 2003Steroid-free liver transplantation in childrenLancet36220682070CrossRefPubMed
10.
Aw, MM, Taylor, RM, Verma, A,  et al. 2003Basiliximab for the treatment of steroid-resistant rejection in pediatric liver transplanted recipients: a preliminary experienceTransplantation75796799CrossRefPubMed
Metadata
Title
Hepatofugal portal flow due to acute cellular rejection
Authors
Y. Kyoden
Y. Sugawara
Y. Matsui
Y. Kishi
N. Akamatsu
M. Makuuchi
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 3/2005
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-004-0269-1

Other articles of this Issue 3/2005

Abdominal Radiology 3/2005 Go to the issue

OriginalPaper

Hepatosplenic brucelloma: clinical presentation and imaging features in six cases

OriginalPaper

Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension: effects of obliteration of major portosystemic shunts

OriginalPaper

Abstracts of selected papers from the current literature

OriginalPaper

Comparison of contrast-enhanced power Doppler ultrasound (Levovist) and computed tomography in alveolar echinococcosis

Invited update

Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging

OriginalPaper

Magnetic resonance T1 gradient-echo imaging in hepatolithiasis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits